Patents 4 Patients pilot extended through June 30, 2020

[[VIEW_THIS]]

Patents 4 Patients pilot extended

In response to the continued interest of stakeholders around the world, the USPTO has extended the Patents 4 Patients Cancer Immunotherapy Pilot Program through June 30, 2020. All pilot parameters remain the same as first implemented on June 29, 2016.

The Extended Missing Parts Pilot Program has not been extended and will end January 2, 2019 as scheduled.

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter@subscriptions.uspto.gov.